190 related articles for article (PubMed ID: 20309753)
1. Special issue of statistical genetics and genomics in clinical trials: guest editor's note.
Wu R; Lin M
J Biopharm Stat; 2010 Mar; 20(2):191-2. PubMed ID: 20309753
[No Abstract] [Full Text] [Related]
2. A systems biology approach for identifying novel pathway regulators in eQTL mapping.
Li S; Lu Q; Cui Y
J Biopharm Stat; 2010 Mar; 20(2):373-400. PubMed ID: 20309764
[TBL] [Abstract][Full Text] [Related]
3. Guest editor's note: missing data--moving forward.
Soon GG
J Biopharm Stat; 2011 Mar; 21(2):177-9. PubMed ID: 21390994
[No Abstract] [Full Text] [Related]
4. Guest editor's note: Special issue on biosimilarity assessment.
Chang VY; Endrenyi L
J Biopharm Stat; 2017; 27(2):195-196. PubMed ID: 27977325
[No Abstract] [Full Text] [Related]
5. Note on special technical issue on adaptive designs for clinical trials.
Liu Q; Chang M
J Biopharm Stat; 2012; 22(4):615-6. PubMed ID: 22651104
[No Abstract] [Full Text] [Related]
6. A note on special articles on adaptive clinical trial designs.
Chow SC
J Biopharm Stat; 2010 Nov; 20(6):1088-9. PubMed ID: 21058103
[No Abstract] [Full Text] [Related]
7. Case-only analysis of treatment-covariate interactions in clinical trials.
Vittinghoff E; Bauer DC
Biometrics; 2006 Sep; 62(3):769-76. PubMed ID: 16984319
[TBL] [Abstract][Full Text] [Related]
8. Special issue on active controlled clinical trials: guest editor's note.
Tsong Y
J Biopharm Stat; 2007; 17(2):197-9. PubMed ID: 17365217
[No Abstract] [Full Text] [Related]
9. Guest editors' note: Special issue on subgroup analysis in clinical trials.
Wang SJ; Dmitrienko A
J Biopharm Stat; 2014; 24(1):1-3. PubMed ID: 24392974
[No Abstract] [Full Text] [Related]
10. Further discussion on the design and analysis of thorough QTc clinical trials: guest editors' notes.
Tsong Y; Zhang J
J Biopharm Stat; 2010 May; 20(3):493-6. PubMed ID: 20358431
[No Abstract] [Full Text] [Related]
11. Detection of coregulation in differential gene expression profiles.
Perco P; Kainz A; Mayer G; Lukas A; Oberbauer R; Mayer B
Biosystems; 2005 Dec; 82(3):235-47. PubMed ID: 16181729
[TBL] [Abstract][Full Text] [Related]
12. Sequentially testing for a gene-drug interaction in a genomewide analysis.
Kelly P; Zhou Y; Whitehead J; Stallard N; Bowman C
Stat Med; 2008 May; 27(11):2022-34. PubMed ID: 17979181
[TBL] [Abstract][Full Text] [Related]
13. Genomics and personalized medicine.
Meadows M
FDA Consum; 2005; 39(6):12-7. PubMed ID: 16669113
[No Abstract] [Full Text] [Related]
14. Another STEPP in the right direction.
Bonetti M; Cole BF; Gelber RD
J Clin Oncol; 2008 Aug; 26(22):3813-4; author reply 3814-5. PubMed ID: 18669475
[No Abstract] [Full Text] [Related]
15. Microarray data analysis: from disarray to consolidation and consensus.
Allison DB; Cui X; Page GP; Sabripour M
Nat Rev Genet; 2006 Jan; 7(1):55-65. PubMed ID: 16369572
[TBL] [Abstract][Full Text] [Related]
16. Commentary on 'Measurement in clinical trials: a neglected issue for statisticians?'.
Wittes J
Stat Med; 2009 Nov; 28(26):3220-2; discussion 3223-5. PubMed ID: 19842097
[No Abstract] [Full Text] [Related]
17. Some statistical and regulatory issues in the evaluation of genetic and genomic tests.
Campbell G
J Biopharm Stat; 2004 Aug; 14(3):539-52. PubMed ID: 15468751
[TBL] [Abstract][Full Text] [Related]
18. Special issue on computational statistical methods for genomics and systems biology.
Labbe A; Dudoit S
Stat Appl Genet Mol Biol; 2012 Jan; 11(2):. PubMed ID: 22499689
[TBL] [Abstract][Full Text] [Related]
19. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
20. Sample size re-estimation for adaptive sequential design in clinical trials.
Gao P; Ware JH; Mehta C
J Biopharm Stat; 2008; 18(6):1184-96. PubMed ID: 18991116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
